Todd Hansen, MD
Phlebology · Ocoee, FLNPI 1215983978
Payments from drug & device makers
What this record shows
The money is spread across several categories — other (54.0%), education and food and beverage — rather than concentrated in one kind of arrangement. Angiodynamics, Inc. accounts for 97.9% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2023 at $4,866 and has fallen 99.4% since, to $31 in 2025.
Across 19 payments — averaging $935.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$17K
- Medtronic$133
- Tactile Systems Technology Inc$96
- Pfizer$50
- Johnson & Johnson$28
- Smith+Nephew$20
- plus $40 from 3 others
What the payments were for
- Food & beverage$3672%
- Education$7,81344%
- Other$9,60054%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 5 | $17,413 |
| Medtronic | 2 | $133 |
| Tactile Systems Technology Inc | 3 | $96 |
| Pfizer | 3 | $50 |
| Johnson & Johnson | 2 | $28 |
| Smith+Nephew | 1 | $20 |
| Hartmann USA, Inc. | 1 | $15 |
| Cashflow Solutions, LLC | 1 | $14 |
| Kerecis Limited | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VenaCure 1470 Pro$14,400
- EVLT$3,013
- Abre$118
How this compares
Too few phlebology providers in Floridato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metoprolol Tartrate | 11 | $17 |
Paid to pharmacies, not to this prescriber.
Other phlebology in Ocoee
- Ammar SaatiOcoee$348
- Saluja GoldmanJupiter$4K
- Alexander GoldmanJupiter$4K
- Golta RasouliVenice$2K
- Federico RichterBradenton$2K
- Daniel MountcastleSt Petersburg$601
- Zoraida NavarroWest Palm Beach$462
- David ShevitzBoca Raton$407
- Charles SteinPalm Coast$131
- John MaurielloLake Mary$62
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.